Integrated Wealth Management (Palm Desert)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$1.77M Sell
54,542
-125
-0.2% -$3.94K 0.59% 50
2016
Q4
$1.69M Sell
54,667
-6,058
-10% -$185K 0.63% 45
2016
Q3
$1.95M Buy
60,725
+4,021
+7% +$134K 0.7% 35
2016
Q2
$1.89M Sell
56,704
-769
-1% -$24.5K 0.73% 32
2016
Q1
$1.62M Sell
57,473
-2,682
-4% -$76.6K 0.68% 36
2015
Q4
$1.84M Sell
60,155
-3,455
-5% -$109K 0.79% 26
2015
Q3
$1.9M Sell
63,610
-1,768
-3% -$56.7K 0.83% 25
2015
Q2
$2.08M Buy
65,378
+708
+1% +$23.1K 0.81% 25
2015
Q1
$2.13M Buy
+64,670
New +$2.06M 0.89% 22

Other funds holding PFE

Integrated Wealth Management (Palm Desert)'s PFE Position: Q1 2017 in Review

Integrated Wealth Management (Palm Desert) reduced its Pfizer (PFE) stake by 0.23% in Q1 2017, selling an estimated $3.94K and leaving 54,542 shares worth $1.77M. The position accounts for 0.59% of the portfolio, ranked #50.

Integrated Wealth Management (Palm Desert) first reported a position in PFE in Q1 2015 and has held it in 9 quarters since. The position peaked at $2.13M in Q1 2015. 2,075 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

  • Integrated Wealth Management (Palm Desert) held 54,542 shares of Pfizer worth $1.77M as of Q1 2017.
  • Integrated Wealth Management (Palm Desert) sold 125 Pfizer shares in Q1 2017, an estimated $3.94K.
  • Pfizer made up 0.59% of Integrated Wealth Management (Palm Desert)'s portfolio in Q1 2017, its #50 holding.
  • Integrated Wealth Management (Palm Desert) first reported a position in Pfizer in Q1 2015 and has held it in 9 quarters since.
  • Integrated Wealth Management (Palm Desert)'s Pfizer position peaked at $2.13M in Q1 2015.
  • 2,075 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q1 2017, filed 14 Apr 2017.